ReShape Lifesciences Faces Delisting Concerns
Ticker: HIND · Form: 8-K · Filed: May 30, 2025 · CIK: 1427570
| Field | Detail |
|---|---|
| Company | Reshape Lifesciences Inc. (HIND) |
| Form Type | 8-K |
| Filed Date | May 30, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
ReShape Lifesciences might get delisted - big trouble for the stock.
AI Summary
ReShape Lifesciences Inc. filed an 8-K on May 30, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of May 28, 2025. The company, formerly known as Obalon Therapeutics Inc., is incorporated in Delaware and has its principal executive offices in Irvine, California.
Why It Matters
This filing indicates potential issues with ReShape Lifesciences' continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards is a significant event that can lead to severe consequences for a company's stock and operations.
Key Players & Entities
- ReShape Lifesciences Inc. (company) — Registrant
- May 28, 2025 (date) — Date of earliest event reported
- May 30, 2025 (date) — Date of report
- Obalon Therapeutics Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Irvine, CA (location) — Address of principal executive offices
- 949-429-6680 (phone_number) — Registrant's telephone number
FAQ
What specific listing rule or standard has ReShape Lifesciences Inc. failed to satisfy?
The filing does not specify the exact listing rule or standard that has not been met, only that a notice has been issued.
What is the exact date of the notice of delisting or failure to satisfy a continued listing rule?
The earliest event reported, which is the date of the notice, is May 28, 2025.
When was this Form 8-K filed with the SEC?
This Form 8-K was filed on May 30, 2025.
What was ReShape Lifesciences Inc. formerly known as?
ReShape Lifesciences Inc. was formerly known as Obalon Therapeutics Inc.
Where are ReShape Lifesciences Inc.'s principal executive offices located?
The principal executive offices are located at 18 Technology Drive, Suite 110, Irvine, CA 92618.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding ReShape Lifesciences Inc. (HIND).